Another coronavirus vaccine candidate has shown promising results in a Phase 1/2 trial conducted in the US. An mRNA experimental drug made by BioNTech, which partnered with Pfizer for the development of the >>

Another potential coronavirus vaccine might be available this fall. Pfizer said the candidate it’s developing with BioNTech could be ready by October if everything goes well. There’s no guarantee that any of these >>